Biocon share news, announcements and annual reports
NSE: BIOCONBSE: 532523Pharmaceuticals & BiotechnologyMid Cap
Biocon Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 2004
Last close ₹351.90up ₹1.20 (0.34%)BSE ₹352.00
Share price at the NSE close on 29 Oct 2026. Previous close ₹350.70.
29 Oct: open ₹351.50, high ₹357.30, low ₹349.40
52-week range of traded prices to 29 Oct 2026
₹318.40Low, 23 Oct 2026₹447.15High, 16 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹57,349 Cr173rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 115.79
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹399 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 64.11
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.69
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.14%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 1.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹399 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 2.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 31,13,378
Biocon board meetings
141 filed, newest first. Page 1 of 3.
Oct 2026
26 Oct · Board meeting
Jul 2026
28 Jul · Board meeting
May 2026
7 May · Board meeting
7 May · Board meeting
Apr 2026
Mar 2026
27 Mar · Board meeting
Feb 2026
12 Feb · Board meeting
Jan 2026
13 Jan · Board meeting
Dec 2025
6 Dec · Board meeting
3 Dec · Board meeting
Nov 2025
11 Nov · Board meeting
Oct 2025
1 Oct · Board meeting
Sep 2025
28 Sep · Board meeting
9 Sep · Board meeting
Aug 2025
7 Aug · Board meeting
Jul 2025
9 Jul · Board meeting
8 Jul · Board meeting
Jun 2025
26 Jun · Board meeting
Apr 2025
23 Apr · Board meeting
20 Apr · Board meeting
4 Apr · Board meeting
1 Apr · Board meeting
Jan 2025
30 Jan · Board meeting
27 Jan · Board meeting
22 Jan · Board meeting
Oct 2024
30 Oct · Board meeting
Aug 2024
8 Aug · Board meeting
Jul 2024
17 Jul · Board meeting
Apr 2024
Feb 2024
8 Feb · Board meeting
8 Feb · Board meeting
Jan 2024
10 Jan · Board meeting
Nov 2023
10 Nov · Board meeting
Oct 2023
Aug 2023
10 Aug · Board meeting
Jul 2023
21 Jul · Board meeting
May 2023
23 May · Board meeting
Apr 2023
26 Apr · Board meeting
26 Apr · Board meeting
20 Apr · Board meeting
Meeting on 23 May 2023: “BIOCON LIMITED has informed the Exchange about Board Meeting to be held on 23-May-2023 to consider financial statements for the period ended March 2023, Financial results/Dividend.”
Jan 2023
6 Jan · Board meeting